Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond.

Nanomaterials exhibit significant potential for stimulating immune responses, offering both local and systemic modulation across a variety of diseases. The lymphoid organs, such as the spleen and lymph nodes, are home to various immune cells, including monocytes and dendritic cells, which contribute to both the progression and prevention/treatment of diseases. Consequently, many nanomaterial formulations are being rationally designed to target these organs and engage with specific cell types, thereby inducing therapeutic and protective effects. In this review, we explore crucial cellular interactions and processes involved in immune regulation and highlight innovative nano-based immunomodulatory approaches. We outline essential considerations in nanomaterial design with an emphasis on their impact on biological interactions, targeting capabilities, and treatment efficacy. Through selected examples, we illustrate the strategic targeting of therapeutically active nanomaterials to lymphoid organs and the subsequent immunomodulation for infection resistance, inflammation suppression, self-antigen tolerance, and cancer immunotherapy. Additionally, we address current challenges, discuss emerging topics, and share our outlook on future developments in the field.

Significance of successive feeding of sources of n-3 fatty acids to broiler breeders and their progeny on growth performance, intestinal lesion scores, lymphoid organs weight and plasma immunoglobulin A in broiler chickens challenged with Eimeria.

The study examined the effects of successive feeding of sources of n-3 PUFA to broiler breeders (BB) and their progeny in broiler chickens challenged with Eimeria. The BB were fed: 1) control (CON), corn-soybean meal diet, 2) CON + 1 % microalgae (DMA), as a source of DHA and 3) CON + 2.50% co-extruded full fat flaxseed (FFF), as a source of ALA. Eggs were hatched at 34, 44, and 54 wk of age. Posthatch treatments (BB-progeny) were: CON-CON, DMA-CON, FFF-CON, DMA-DMA and FFF-FFF with diets formulated for starter (d 1-10) and grower/finisher (d 11-42) phases. All chicks were orally challenged with Eimeria (E. acervulina and E. maxima) on d 10. Relative to CON, DMA and FFF increased concentration of n-3 PUFA by ≥ 2-fold in hatching eggs and progeny diets. There were no (P > 0.05) interactions between treatment and BB age on d 0 to 10 growth. In general, BB age affected (P < 0.05) growth performance throughout the study. In the starter phase, successive exposure to DHA and ALA improved FCR over CON-CON (P < 0.01). The interaction between treatment and BB age in grower/finisher was such that DHA exposure to younger BB resulted in poor growth performance (P < 0.05) relative to exposure to older BB. In contrast, exposure to ALA had similar (P > 0.05) growth performance irrespective of BB age. Moreover, successive exposure to ALA resulted in higher BWG, breast weight and lower FCR compared to successive exposure to DHA (P < 0.05). There were no (P > 0.05) interactions between treatment and BB age on the intestinal lesion scores, lymphoid organ weights and concentration of plasma immunoglobulin A (IgA). Successive exposure to DHA resulted in higher (P = 0.006) jejunal lesion scores than CON-CON birds. The results showed that successive exposure of DHA and ALA improved FCR relative to non-exposed birds in the starter phase. However, responses in the grower/finisher phase depended on n-3 PUFA type, with birds on successive ALA exposure supporting better growth and breast yield than birds on successive DHA exposure.

Effect of RN-301 immunomodulator on bronchus-associated lymphoid tissue (Balt) in protein depleted rats at weaning

It has been previously demonstrated in Wistar rats that severe protein deprivation at weaning, even after refeeding with a 20 percent casein diet for 21 days, provokes alterations in IgA+ B cell and T cell populations from gut and GALT (gut associated lymphoid tissue) that are reverted by immunomodulator IM-104. In the present report, we investigated the influence of RN-301 (quite similar to IM-104) given by the oral or subcutaneous route during the protein deprivation period, in the seeding of BALT with IgA+ B and CD5+T cells. The immunomodulator RN-301 contains LPS from E. coli and membrane and ribosomal fractions of P. acne. Tissue sections of the lower respiratory tract were studied by immunohistochemistry. The immunomodulator RN-301 administered by the oral route favours the significant increase in the seeding of the BALT lamina propria with IGA+B and CD5+T cells (p < 0.001). However, the RN-301 given by the subcutaneous route does not favour the repopulation of the BALT lamina propria. The ribosomal fractions from P. acne associated with LPS from E. coli contained in the immunomodulator RN-301 administered by the oral route may rescue the small resting lymphocytes in the gut-associated lymphoid tissue (GALT). This event favours their proliferation and migration to the BALT.

Imunossupressäo experimental em camundongos: aspectos histopatológicos dos órgäos linfóides após tratamento com dexametasona e inoculaçäo de Candida albicans / Experimental imunossupressin in mice: histologycal aspects of the linfoid tissue after administration of dexamethasone and inoculation with Candida albicans

Foi realizada imunossupressäo experimental com corticosteróides em camundongos usando 1 mg/kg/dia de exametsona durante uma semana. Para verificar os efeitos imunossupressores da droga, sobre os tecidos linfóides, inoculamos 1 ml de 1.10 de Candida albicans, por via endovenosa, após o tratamento. Observamos a instalaçäo e evoluçäo da infecçäo durante doze dias e analisamos os aspectos histológicos do baço, timo, linfonodos, rins, fígado, pulmöes e pele, que foram retirados, em intervalos regulares, de animais tratados somente com dexametasona e somente com Candida albicans, ou com ambos os dois tratamentos. Os resultados obtidos nos levaram a concluir que ocorre imunossupressäo com essa dosagem de dexametasona e que o baço foi o órgäo mais atingido. A candidíase isoladamente também provocou imunossupressäo, afetando principalmente o timo. Os efeitos imunossupressores dos dois tratamentos se somaram quando houve a associaçäo dos mesmos

Alteraçöes metabólicas e funcionais em células e órgäos do sistema imunológico de ratos induzidas pela administraçäo intragástrica do óleo de peixe / Metabolic and functional changes in cells and organs of immune system of rats due to the fish oil administrated by gavage

O consumo de cápsulas de óleo de peixe (OP) por humanos visa a atenuaçäo dos sintomas e prevençäo de várias patologias. As alteraçöes metabólicas e funcionais em células e órgäos do sistema imunológico causadas pelo OP pela administraçäo intragástrica (AIG) foram avaliadas. Ratos recém-desmamados (50-70 g) foram submetidos a AIG diária com óleo de peixe, óleo de soja ou manteiga de cacau (0,4 por cento do peso), por 28 dias. Os dados da AIG do OP foram também comparados com os da dieta enriquecida com OP. Foram avaliados: aumento de permeabilidade vascular (reaçäo anafilática), funcionalidade de macrófagos (produçäo de 'H IND. 2O IND. 2', 'O IND. 2' e fagocitose), proliferaçäo de linfócitos, a atividade máxima das enzimas: hexoquinase, glicose-6-fosfato desidrogenase, citrato sintase (metabolismo de glicose), catalase, glutationa peroxidase e superóxido dismutase (antioxidantes) no baço, linfonodo mesentérico e timo. A concentraçäo de TBARs nos mesmos órgäos e no plasma e a capacidade antioxidante do plasma foram também determinadas